A detailed history of Steward Financial Group LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Steward Financial Group LLC holds 409 shares of GILD stock, worth $36,024. This represents 0.01% of its overall portfolio holdings.

Number of Shares
409
Previous 408 0.25%
Holding current value
$36,024
Previous $31,000 3.23%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 20, 2023

BUY
$73.94 - $80.67 $73 - $80
1 Added 0.25%
409 $30,000
Q2 2023

Aug 04, 2023

BUY
$76.01 - $86.7 $31,012 - $35,373
408 New
408 $31,000
Q2 2022

Jul 22, 2022

BUY
$57.72 - $65.01 $8,600 - $9,686
149 New
149 $9,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Steward Financial Group LLC Portfolio

Follow Steward Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Financial Group LLC with notifications on news.